Posted on

Government Will Have to Turn Over Records of Dr. Fauci’s Official Communications as Part of a “suppression of speech “Lawsuit by Attorney Generals in Louisiana and Missouri

external content.duckduckgo 28

the staff of the Ridgewood blog

Washington DC, as previously reported on this blog Dr. Anthony Fauci has announced his retirement but he may not be able to continue unaccountability for his actions over COVID indefinitely.

Continue reading Government Will Have to Turn Over Records of Dr. Fauci’s Official Communications as Part of a “suppression of speech “Lawsuit by Attorney Generals in Louisiana and Missouri

Posted on

Pharmaceutical Companies Next on the Democrats Hit List

external content.duckduckgo 61

the staff of the Ridgewood blog

Trenton NJ, New Jersey advertises itself as the “Medicine Chest of the World.” Nine of the largest drug companies in the nation are either headquartered in, or have major operations clustered in the Garden State.
Continue reading Pharmaceutical Companies Next on the Democrats Hit List

Posted on

Pharmaceutical companies are pushing to develop more effective, easily administered therapeutics for COVID-19

Assay portal scaled
the staff of the Ridgewood blog
Ridgewood NJ, Pharmaceutical companies are pushing to develop more effective, easily administered therapeutics for COVID-19, some of which are being studied for the prevention of SARS-CoV-2 infection. This morning, Merck announced that its investigational oral antiviral molnupiravir, which is being developed with Ridgeback Biotherapeutics, significantly reduced the risk of hospitalization or death among non-hospitalized adult COVID-19 patients with mild-to-moderate symptoms who were considered high risk due to other health conditions such as obesity, diabetes, or heart disease. Among patients who took a 5-day course of the drug, 7.3% (28/385) were hospitalized or died compared with 14.1% (53/377) of patients who took a placebo, according to the interim analysis of the Phase 3 MOVe-OUT trial. Merck said it will file an application for Emergency Use Authorization (EUA) with the US FDA as soon as possible, as well as filing applications for marketing with regulatory agencies globally. Over the summer, the US government announced plans to purchase 1.7 million courses of molnupiravir from Merck for about US$1.2 billion, pending US FDA authorization or approval. If authorized, the drug would become the first oral medication available to treat COVID-19.

Continue reading Pharmaceutical companies are pushing to develop more effective, easily administered therapeutics for COVID-19